In situ hybridization was used to evaluate patterns of gene expression for glucose transporters 1-4 (GT14) in the rat uteroplacenta from the time of implantation through term, and in vivo regional placental glucose metabolism was measured by '4C-labeled 2-deoxyglucose uptake. GT1 mRNA was highly abundant and GT3 was barely detected in the postimplantation decidual reaction. GT1 and 3 mRNAs were colocalized in the labyrinthine syncitiotrophoblast layer of the chorioallantoic placenta, which forms the membranous barrier between maternal and fetal circulations. The level of labyrinthine GT3 mRNA showed no change from midgestation through term; however, the volume of the labyrinth and hence total GT 3 gene expression increased greatly during this period. Labyrinthine GT1 mRNA levels, in contrast, showed significant diminution near term. GT1 mRNA was also localized in the placental growth plate, or junctional zone, where it was most abundant during the period of rapid placental growth and was decreased at term. Placental glucose metabolism, as reflected by steady-state 2-deoxyglucose uptake, was highest in the junctional zone during the rapid growth phase during midgestation, and decreased significantly at term, in parallel with GT1 gene expression. These findings suggest that GT1 is responsible for supplying glucose for use as a placental fuel and that GT3 is important for glucose transfer to the embryo. (J. Clin. Invest. 1993. 91:845-852.) 
Introduction
Glucose is the major fuel for energy metabolism and growth in embryogenesis, and yet the mammalian embryo is unable to manufacture this essential substrate until late in development (reviewed in references 1 and 2). Hence, the transfer ofglucose from the maternal circulation to the conceptus is a crucial feature ofmammalian development. The placenta plays a key role in this transfer process, which appears to be primarily a function of facilitated glucose transport down a concentration gradient from maternal to fetoplacental compartments (3, 4) . The molecular basis for placental glucose transport and its regulation remain poorly understood at present.
In recent years, there has been rapid progress in elucidating the molecular basis for glucose transport across cell membranes. At least five different facilitative glucose transporters (GTs 1-5,' named in order oftheir cloning) have been charac-terized to date (reviewed in references 5 and 6). These integral membrane glycoproteins display significant sequence homology and appear to be members of a genetically related transporter family. The glucose transporter isoforms show unique tissue-specific patterns of distribution and may be subject to differential hormonal regulation (8) . For example, GT4 is preferentially expressed in fat and muscle and is regulated by insulin (7, 9) . GT2 is localized in pancreatic beta cells, hepatocytes, renal proximal tubules, and intestinal epithelium (6, 10) , while GT5 appears to be expressed primarily in intestinal epithelium (7) .
To our knowledge, the molecular identity and anatomical disposition ofplacental glucose transporters has not been previously examined. Since this knowledge may illuminate the mechanisms governing the vectorial transfer of glucose between maternal and fetoplacental compartments, we undertook the mapping ofglucose transporter gene expression in the rat uteroplacenta from implantation through term. For this purpose, we used in situ hybridization histochemistry using highly sensitive 35S-labeled cRNA probes complementary to rodent GT 1-4 cDNAs. In addition, since one ofthe key factors in fetoplacental maternal fuel economy is placental glucose utilization, we used in vivo radiolabeled 2-deoxyglucose uptake to evaluate regional and developmental patterns of placental glucose utilization.
Methods
Animals and 2-deoxwyglucose uptake. Timed Riboprobes. GT 1 sense and antisense probes were synthesized from a 436-bp Bam H I fragment corresponding to bases 272-708 of the rat GT I cDNA (kindly provided by Dr. M. J. Birnbaum, Harvard Medical School, Boston, MA; reference 11), which was subcloned into pGEM-3 for transcription of the antisense probe using T7 RNA polymerase after linearization with HindIII, and for generation of a sense, control probe by SP6 after linearization with EcoR 1. The GT2 probe was synthesized from a 41 8-bp fragment of the rat GT2 cDNA (kindly supplied by Dr. H. F. Lodish, Whitehead Institute for Biomedical Research, MIT, Cambridge, MA; reference 10) corresponding to nucleotides -18-400, subcloned into pGEM4, and linearized with EcoR 1 for transcription of antisense with T7. The GT3 probe was synthesized from a mouse GT3 cDNA fragment, coding for amino acids 207-394, subcloned into pGEM4Z, and transcribed in antisense orientation by T7 after linearization with EcoRI (kindly provided by Dr. G. I. Bell, University ofChicago, Chicago, IL; reference 12). The GT4 probe was synthesized from a 364-bp rat GT4 cDNA fragment corresponding to 95 bases of the COOH-terminal and 269 bases of the 3' untranslated region (kindly supplied by Dr. M. J. Birnbaum; reference 9), subcloned into pGEM4Z, and transcribed with T7 after linearization with EcoR 1. Northern blots of rat placental RNA were probed with "P-labeled GTI and GT3 riboprobes, and yielded single bands of -2.8 and 4.0 kb, respectively (our unpublished data).
In situ hybridization. The synthesis of "S-labeled cRNA probes and in situ hybridization protocol has been previously described ( 13) . In brief, cRNA probes were synthesized in 10-Ml reactions containing 100 ACi`S -CTP and 100 ,ACi 3"S-UTP, 10 mM NaCl, 6 mM MgC12, 40 mM Tris (pH 7.5), 2 mM spermidine, 10 mM DTT, 500 ,gM each unlabeled ATP and GTP, 25 gM each unlabeled UTP and CTP, 500 ng linearized template, 15 U of the appropriate polymerase, and 15 U RNasin (enzymes and other molecular biology reagents were obtained from Promega, Madison, WI). The reaction was incubated at 42°C for 60 min, after which the DNA template was removed by digestion with DNase I. Average specific activity of probes generated in this protocol was 2 X 108 dpm/Ag.
Before hybridization, sections were warmed to 25°C, fixed in 4% formaldehyde, and soaked for 10 min in 0.25% acetic anhydride/0. 1 M triethanolamine hydrochloride/0.9% NaCl. Tissue was dehydrated through an ethanol series, delipidated in chloroform, rehydrated, and air dried. 3"S-labeled probes were added to hybridization buffer (I0' cpm/ml) composed of 50% formamide, 0.3 M NaCl, 20 mM Tris HCl, pH 8, 5 mM EDTA, 500 ,ug transfer RNA/ml, 10% dextran sulfate, 10 mM DTT, and 0.02% each of BSA, ficoll, and polyvinylpyrollidone. Hybridization buffer was added to sections that were incubated under glass coverslips overnight ( 14 h Sections from the different gestational age groups were prepared, hybridized, washed, exposed, and developed together to facilitate comparison of signal intensity across the different developmental stages.
Figures containing autoradiographs and micrographs comparing different ages represent data acquired in a single experiment. Controls in the form of parallel tissue sections hybridized to a GTI "sense" probe or pretreated with RNase A were hybridized, washed, and exposed in the same experiments. The background or nonspecific signal from these sections was very minimal.
Results
Preplacental glucose transporter gene expression. During early pregnancy, there is a robust proliferation of endometrial stromal tissue forming a lush bed for implantation of the blastocyst. GTI mRNA is extremely abundant in this decidual reaction, while relatively little GT3 mRNA is detected ( Fig. 1 ). In the nonpregnant uterus, GTI mRNA is detected only in the luminal epithelium and none of the other GT mRNAs are detected (data not shown). mRNAs are quite abundant in the early postimplantation embryo and embryonic membranes (Fig. 1, A-C (Fig. 3 A) . The labyrinthe is the transplacen- GT1 mRNA is abundant in both labyrinthine and junctional zones of the El 4 placenta (Fig. 3 C) . GT1 mRNA levels decrease between E 14 and E20, with the decrease most pronounced in the junctional zone (Fig. 3, C and D) . In contrast to the pattern ofGTI expression, GT3 mRNA is detected solely in the placental labyrinth and levels do not change significantly during the course ofgestation (Fig. 3, E and F) . Both GT 1 and GT3 mRNAs are concentrated in the uterine metrial glands near the end of pregnancy (Fig. 3, D and F) .
Glucose from the maternal bloodstream must pass through the trilaminar trophoblast epithelium to reach the fenestrated fetal capillaries (Fig. 4 E) . Outermost is a fenestrated cytotrophoblast layer beneath which are two syncitiotrophoblast layers that constitute the only barriers to the free diffusion of glucose from maternal to fetal bloodstreams (reference 14, Fig.  4 E) . Both GTI and GT3 mRNAs are localized in the trabecular syncitiotrophoblast (Fig. 4) . These syncitial layers are so thin and closely approximated that it is impossible to differentiate them at the light microscopic level, and, likewise, the isotopic signal cannot be parsed between the different layers. GT1 mRNA is clearly present in the cytotrophoblast as well as syncitiotrophoblast layers (Fig. 4, C and D) , while GT3 mRNA appears to be expressed only in the inner syntiotrophoblast.
This distinction cannot be stated unequivocally, given the above-noted limitations in resolution; however, it is supported by the relative differences in abundance in labyrinthine GTI and GT3 mRNAs. Although it is not standard to compare levels ofdifferent mRNAs based on signal intensities generated by different probes, since probe efficiency may vary, in this case, we have internal markers ofprobe efficiency suggesting that the lower levels of GT3 hybridization signal arising from the labyrinth are not caused by any inherent weakness in the GT3 probe. For example, as seen in Figs. 1 and 2 , GT3 mRNA hybridization signal in the yolk sac is higher than that of GT 1, and both probes show equal intensity in the uterine metrial glands, while GTI shows greater signal in the labyrinth than GT3 (Fig. 3, D and F) .
Placental glucose metabolism. Regional and developmental patterns of placental glucose metabolism were evaluated in vivo using the radiolabeled deoxyglucose ('4C-2DG) uptake technique ( 15) . The glucose analog, 2-deoxyglucose, competes effectively with glucose for transport via facilitative glucose transporters and is phosphorylated by glucose kinase to yield '4C-2DG-6-phosphate. This product resists further metabolism and is unable to pass through glucose transport channels, so it is essentially trapped inside metabolically active cells, where it may be visualized in histological sections by film autoradiography. Thus, 2DG is concentrated in cells where there is both efficient transport and utilization, as reflected by phosphorylation. High levels ofglucose flux, in the absence oftrapping, are not detected by 2DG. 2DG concentration in the E14 placenta is maximal 30 min after injection ofthe tracer and is primarily concentrated in the junctional zone (Fig. 5) . E20 placentas showed a much diminished '4C-2DG concentration, with only a slight differential in favor of the junctional zone (Fig. 6 E) . Developmental and regional patterns of GT1 gene expression and 2DG uptake are compared in Fig. 6 .
Discussion
This is the first study to use in vivo radiolabeled 2DG uptake for the direct examination of placental glucose metabolism. Previous studies have compared the glucose concentration of uterine and umbilical vessels and have shown that the uteroplacenta itself consumes a considerable portion ofthe glucose destined for the fetoplacental compartment (4), but the anatomical and developmental distribution ofplacental glucose utilization have not been known. The present study suggests that 2DG is preferentially concentrated in the junctional zone and is most abundant during the time of rapid placental growth. This zone is the region of cytotrophoblast proliferative and expansionist activity, suggesting that high levels ofglucose metabolism may be related to local growth. The low level of 2DG localized in the labyrinthine zone suggests that glucose transport in this region is primarily a function oftransfer to the fetus with a relatively low level utilization by labyrinthine cells. This study has also described the spatiotemporal patterns of glucose transporter gene expression in the developing rat gestation. GT1 gene expression is abundant in tissues demonstrating proliferative growth and high glucose utilization, while GT3 expression is preferentially associated with structures engaged in the transplacental transfer of glucose, with a significant overlap in GTI and GT3 expression noted in the trophoblast transport membranes. High levels of GTI mRNA are present in the proliferative endometrium of the peri-implantation decidual reaction and in the junctional zone during the midgestational period of rapid placental growth, associated with high 2DG uptake in this region. GTI mRNA levels decline in concert with diminishing levels of 2DG uptake, and presumably, a decreased growth rate in the term placenta. These findings are in agreement with the idea that GTI functions as a constitutive, growth-associated glucose transporter, as suggested by the increased GTI expression and high glucose metabolism noted in transformed or growth factor-treated cells and established cell lines (5) (6) (7) .
The anatomical organization of the rat and human placentas are very similar, and both distribute the afferent maternal blood flow first to the junctional zone (in the human, the basal plate) and then to the labyrinthine zone. Hence, the metabolically active cells of the junctional zone have anatomical priority in the reception of maternal glucose, which ensures that the growing placenta will get enough glucose from the maternal circulation to grow large enough to support the gestation. It has been suggested that the placenta consumes glucose "at the expense of the fetus;" however, considering that the placenta is a fetal organ designed for the attachment and nutritional support of the fetus, its growth is clearly central to fetal development.
GT3 gene expression, in contrast to that of GT 1, is closely correlated with those structures specialized for transfer of nutrients to the embryo, the yolk sac and the labyrinthine zone of the chorioallantoic placenta. The intensity ofGT3 gene expression does not change, but the surface area demonstrating GT3 gene expression increases greatly during the course ofgestation, compatible with the necessity for transferring greater amounts of glucose to the growing fetus. It has been calculated that the placental epithelial surface area for exchange of nutrients such as glucose increases by sevenfold during the last week of the rat gestation, associated with a sevenfold increase in fetal weight ( 16) . GTI and 3 mRNAs are both expressed in the labyrinthine trophoblast epithelium, which constitutes the membranous barrier between maternal and fetal circulations. It is possible that the two mRNAs are segregated into different layers of syncitiotrophoblast; i.e., GTI in the intermediate layer and GT3 in the basal layer approximating the fetal circulation. These syncitial layers are so thin and closely apposed that it is difficult to distinguish them, even at the ultrastructural level ( 14) . It is also possible that transporter expression may be asymmetric in individual epithelial cell layers, with one transporter directed to the maternal surface and the other to the fetal surface. Supporting this possibility is the observation that there appears to be a polarization ofreceptor and enzyme expression in human syncitiotrophoblast membranes (reviewed in reference 17). If GT3 were restricted to the fetal side trophoblast membrane and had a higher affinity for glucose than GT1, as has been reported ( 18) , and GT 1 located on the maternal side membrane, this anatomical arrangement could function like a valve system, promoting the retention of glucose by the fetal circulation during relative maternal hypoglycemia. Previous studies of glucose transport across isolated human and guinea pig placental membranes have suggested that transport through fetal side membrane does in fact occur with a lower Km than via maternal side membranes (reviewed in reference 17). Similarly, the observation that GT1 is selectively expressed by components ofthe blood brain barrier while GT3 is exclusively expressed by neurons has been suggested to promote the vectorial flow of glucose to neurons ( 12, 19, 20) .
The yolk sac, which functions in nutrient transfer before placental development (21, 22) , expresses GT2 in addition to GT 1 and 3 mRNAs. GT2 mRNA is not, however, detected in the chorioallantoic placenta. While it is likely that GTs 1 and 3 serve similar roles in maternal fetal glucose transfer in both the yolk sac and the placenta, it is unclear what role the relatively low affinity GT2 isoform might play in the yolk sac. GT4 gene expression is not detected in yolk sac or placenta, consistent with the view that this transporter functions as an insulin-sensitive mediator of glucose homeostasis (reviewed in reference 23). Although placental tissue has insulin binding sites (24, 25) and insulin receptor mRNA (our unpublished data), placental glucose uptake does not appear to be regulated by insulin (reviewed in reference 26).
In summary, this study has shown that GTI and GT3 appear to be the major placental glucose transporters, and that these two transporters demonstrate distinct anatomical patterns of expression that appear to be functionally significant. GTI alone is localized in regions of high glucose metabolism and GT3 is localized exclusively in regions devoted to the transplacental transfer of glucose, where there is overlapping GTI expression. This arrangement suggests that placental GTI functions to transport glucose from the maternal bloodstream for use as a placental fuel and for further transport via GT3 to the fetal circulation.
